Jeffrey Pepe
2022
In 2022, Jeffrey Pepe earned a total compensation of $2.3M as Former Interim Chief Executive Officer at ARS Pharmaceuticals.
Compensation breakdown
| Option Awards | $476,875 |
|---|---|
| Salary | $364,111 |
| Stock Awards | $161,210 |
| Other | $1,282,654 |
| Total | $2,284,850 |
Pepe received $1.3M in other compensation, accounting for 56% of the total pay in 2022.
Pepe also received $476.9K in option awards, $364.1K in salary and $161.2K in stock awards.
Rankings
In 2022, Jeffrey Pepe's compensation ranked 1,581st out of 5,760 executives tracked by ExecPay. In other words, Pepe earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,581 out of 5,760 | 73rd |
Division Manufacturing | 808 out of 3,136 | 74th |
Major group Chemicals And Allied Products | 319 out of 1,422 | 78th |
Industry group Drugs | 296 out of 1,323 | 78th |
Industry Pharmaceutical Preparations | 210 out of 969 | 78th |
Source: SEC filing on May 1, 2023.
Pepe's colleagues
We found six more compensation records of executives who worked with Jeffrey Pepe at ARS Pharmaceuticals in 2022.
2022
Laura Shawver
ARS Pharmaceuticals
Chief Executive Officer
2022
Valerie Odegard
ARS Pharmaceuticals
Chief Scientific Officer
2022
Jonathan Piazza
ARS Pharmaceuticals
Chief Financial Officer
2022
Richard MSEL
ARS Pharmaceuticals
Chief Executive Officer
2022
Sarina Tanimoto
ARS Pharmaceuticals
Chief Medical Officer
2022
Eric Karas
ARS Pharmaceuticals